ABSTRACT
OBJECTIVES: To study effects of the introduction of pneumococcal conjugate vaccines (PCV) on the interspecies dynamics of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in preschool children with respiratory tract infection. METHODS: Nasopharyngeal samples from children aged ≤6 years with upper respiratory tract infection (n = 14 473) in South Sweden were analysed during 14 consecutive years, 5 years before and 9 years after PCV introduction. The yearly prevalence was calculated, and multivariate count regressions between prevalence and estimated yearly proportions of vaccinated children were performed. Associations between pneumococcal serotypes and the other pathogens were assessed. RESULTS: When comparing the prevaccine period with the years after introduction, the prevalence of S. pneumoniae decreased by 65.2% (16.4 to 5.7 per 1000 individuals; p < 0.001), whereas M. catarrhalis and H. influenzae decreased by 52.1% (21.5 to 10.3 per 1000 individuals; p < 0.001) and 46.6% (13.6 to 7.3 per 1000 individuals; p < 0.001), respectively. In multivariate negative binomial regressions adjusted for yearly numbers of samples taken, S. pneumoniae and M. catarrhalis were significantly negatively associated with increasing vaccine coverage proportions (adjusted prevalence ratio (aPR) = 0.17; p < 0.001 and aPR = 0.48; p < 0.001, respectively), whereas H. influenzae (aPR = 0.75; p = 0.17) was not. In addition, the proportion of cultures positive for S. pneumoniae as well as M. catarrhalis was significantly lower in the postvaccine period compared to the prevaccine period, while this was not the case for H. influenzae. A significant positive association between certain PCV serotypes and simultaneous growth with M. catarrhalis was observed. CONCLUSIONS: After introduction of PCV, the prevalence of M. catarrhalis in addition to S. pneumoniae in children with respiratory tract infection decreased; this was also the case after adjusting for reduced numbers of samples taken. This may partly be attributed to a positive association between PCV serotypes and M. catarrhalis.
Subject(s)
Moraxella catarrhalis/isolation & purification , Moraxellaceae Infections/prevention & control , Pneumococcal Infections/prevention & control , Pneumococcal Vaccines/immunology , Respiratory Tract Infections/microbiology , Streptococcus pneumoniae/isolation & purification , Child, Preschool , Cohort Studies , Haemophilus influenzae/isolation & purification , Humans , Infant , Nasopharynx/microbiology , Pneumococcal Infections/epidemiology , Pneumococcal Infections/microbiology , Retrospective Studies , Sweden/epidemiologyABSTRACT
OBJECTIVE: To perform a comprehensive review of the literature from July 2015 to June 2019 on the pathogenesis of otitis media. Bacteria, viruses and the role of the microbiome as well as the host response are discussed. Directions for future research are also suggested. DATA SOURCES: PubMed database of the National Library of Medicine. REVIEW METHODS: PubMed was searched for any papers pertaining to OM pathogenesis between July 2015 and June 2019. If in English, abstracts were assessed individually for their relevance and included in the report. Members of the panel drafted the report based on these searches and on new data presented at the 20th International Symposium on Recent Advances in Otitis Media. CONCLUSIONS: The main themes that arose in OM pathogenesis were around the need for symptomatic viral infections to develop disease. Different populations potentially having different mechanisms of pathogenesis. Novel bacterial otopathogens are emerging and need to be monitored. Animal models need to continue to be developed and used to understand disease pathogenesis. IMPLICATIONS FOR PRACTICE: The findings in the pathogenesis panel have several implications for both research and clinical practice. The most urgent areas appear to be to continue monitoring the emergence of novel otopathogens, and the need to develop prevention and preventative therapies that do not rely on antibiotics and protect against the development of the initial OM episode.
Subject(s)
Bacterial Infections/complications , Bacterial Infections/microbiology , Microbiota , Otitis Media/microbiology , Virus Diseases/complications , Animals , Biomedical Research , Disease Models, Animal , Ear, Middle/microbiology , Humans , Otitis Media/prevention & control , Otitis Media/virologyABSTRACT
OBJECTIVES: Infections with extended spectrum ß-lactamase (ESBL)-producing Enterobacteriaceae (EPE) are a major healthcare concern. Our goal was to investigate whether a probiotic mixture could be used for eradication therapy in patients with prolonged intestinal EPE carriage. METHODS: We performed a randomized, placebo-controlled, single-blinded clinical superiority trial in the south of Sweden between February 2017 and April 2019. Probiotic Vivomixx®, a mixture of 8 different living bacterial strains or placebo was given to adult outpatients intestinally colonized for at least 3 months with EPE. Patients with suspected active infections at the time of evaluation were excluded, and also those with immunosuppression, severe psychiatric disorder, drug abuse or dementia. Each patient in the probiotic arm was administered 2 sachets (9.0 × 1011 live bacteria) twice daily for 2 months. The primary outcome was intestinal EPE eradication at the end of the 1-year follow-up, as shown by 3 consecutive negative EPE rectal swabs during the follow-up year. The per protocol follow-up for all patients was 1, 3, 6 and 12 months after the initiation of the intervention. ClinicalTrials.gov Identifier: NCT03860415. RESULTS: In total, the target size of 80 patients were included. The median age was 68 years in both groups. The number of females in the probiotics group was 23 (58%) and in the placebo group 28 (70%). At the end of the trial, 12.5% (5 out of 40) of the patients in the probiotic group had achieved successful eradication of EPE, as defined by the primary outcome, in the intention to treat analysis. In the placebo group, 5% (2 out of 40) of the patients had achieved successful eradication of EPE (odds ratio 2.71; 95% confidence interval (CI), 0.49-14.9; p 0.24). CONCLUSIONS: Successful EPE eradication was observed in very few individuals. This trial did not support Vivomixx® as being superior to placebo for intestinal decolonization in adult patients with chronic colonization of EPE, but was limited in power.
Subject(s)
Carrier State/microbiology , Enterobacteriaceae Infections/therapy , Enterobacteriaceae/pathogenicity , Intestines/microbiology , Probiotics/therapeutic use , Administration, Oral , Adult , Aged , Aged, 80 and over , Enterobacteriaceae/enzymology , Feces/microbiology , Female , Humans , Male , Middle Aged , Surveys and Questionnaires , Sweden , Young Adult , beta-LactamasesABSTRACT
Ineffective antimicrobial therapy of Pseudomonas aeruginosa bacteraemia increases mortality. Recent studies have proposed the use of antimicrobial combination therapy composed of a beta-lactam with either ciprofloxacin or tobramycin. To determine if combination therapy correlates to lower mortality and is superior compared to monotherapy, we investigated the effect of antimicrobial treatment regimens on 30-day mortality in a cohort with Pseudomonas aeruginosa bacteraemia. All cases of P. aeruginosa bacteraemia (n = 292) in southwest Skåne County, Sweden (years 2005-2010, adult population 361,112) and the whole county (2011-2012, 966,130) were identified. Available medical and microbiological records for persons aged 18 years or more were reviewed (n = 235). Antimicrobial therapy was defined as empiric at admission or definitive after culture results and was correlated to 30-day mortality in a multivariate regression model. The incidence and mortality rates were 8.0 per 100,000 adults and 22.9% (67/292), respectively. As expected, multiple comorbidities and high age were associated with mortality. Adequate empiric or definitive antipseudomonal treatment was associated with lower mortality than other antimicrobial alternatives (empiric p = 0.02, adj. p = 0.03; definitive p < 0.001, adj. p = 0.007). No difference in mortality was seen between empiric antipseudomonal monotherapy or empiric combination therapy. However, definitive combination therapy including ciprofloxacin correlated to lower mortality than monotherapy (p = 0.006, adj. p = 0.003), whereas combinations including tobramycin did not. Our results underline the importance of adequate antipseudomonal treatment. These data also suggest that P. aeruginosa bacteraemia should be treated with an antimicrobial combination including ciprofloxacin when susceptible.
Subject(s)
Anti-Bacterial Agents/therapeutic use , Bacteremia/drug therapy , Bacteremia/mortality , Ciprofloxacin/therapeutic use , Pseudomonas Infections/drug therapy , Pseudomonas Infections/mortality , Pseudomonas aeruginosa/isolation & purification , Adolescent , Adult , Aged , Aged, 80 and over , Bacteremia/microbiology , Drug Therapy, Combination/methods , Female , Humans , Male , Middle Aged , Mortality , Pseudomonas Infections/microbiology , Pseudomonas aeruginosa/drug effects , Retrospective Studies , Sweden , Treatment Outcome , Young AdultABSTRACT
OBJECTIVES: Increasing incidences of non-typeable Haemophilus influenzae (NTHi) with ß-lactam resistance mediated through mutations in penicillin-binding protein 3 (BLNAR or rPBP3) have been observed in the past decades. Recently, an rPBP3 NTHi sequence type (ST) 14 with PBP3 type IIb/A caused a disease outbreak in a nursing home in Sweden with severe outcomes, indicating increased bacterial virulence. In this prospective observational study, the epidemiology and clinical significance of the corresponding clonal group (ST14CC-PBP3IIb/A) in Skåne, Sweden was investigated. METHODS: ST14CC-PBP3IIb/A isolates were identified through partial multilocus sequence typing and ftsI(PBP3 gene)-sequencing of prospectively collected H. influenzae from patients with respiratory tract or invasive infections (n=3262) in 2010-2012. Data on type of infection, hospitalization and outcomes were analysed, and the geographical distribution of isolates from different groups was investigated. RESULTS: Isolates belonging to ST14CC-PBP3IIb/A constituted 26% (n=94/360) of respiratory tract rPBP3 NTHi. From mapping of patient addresses, a dynamic geographical spread was apparent during the study period. Furthermore, patients with infections by ST14CC-PBP3IIb/A isolates had higher hospitalization rates compared with patients infected with other rPBP3 NTHi (14/83 versus 21/255, p 0.025) and to a group of patients infected with susceptible NTHi (14/83 versus 13/191, p 0.010). ST14CC-PBP3IIb/A isolates constituted 25% (n=2/8) of invasive rPBP3 NTHi during the study period. CONCLUSIONS: Our investigation suggests that the ST14CC-PBP3IIb/A clonal group is associated with increased clinical virulence, resistance to several antimicrobial agents, and is persistent over time. We conclude that virulence varies between different NTHi, and that NTHi disease may be more dependent on bacterial factors than previously recognized.
Subject(s)
Disease Outbreaks , Genotype , Haemophilus Infections/epidemiology , Haemophilus influenzae/classification , Haemophilus influenzae/isolation & purification , Multilocus Sequence Typing , beta-Lactam Resistance , Adolescent , Adult , Aged , Aged, 80 and over , Child , Child, Preschool , Female , Haemophilus Infections/microbiology , Haemophilus Infections/pathology , Haemophilus influenzae/drug effects , Haemophilus influenzae/genetics , Humans , Infant , Infant, Newborn , Male , Middle Aged , Nursing Homes , Penicillin-Binding Proteins/genetics , Prospective Studies , Sequence Analysis, DNA , Sweden/epidemiology , Virulence , Young AdultABSTRACT
The human restricted pathogen Moraxella catarrhalis is an important causal agent for exacerbations in chronic obstructive lung disease in adults. In such patients, increased numbers of granulocytes are present in the airways, which correlate with bacteria-induced exacerbations and severity of the disease. Our study investigated whether the interaction of M. catarrhalis with the human granulocyte-specific carcinoembryonic antigen-related cell adhesion molecule (CEACAM)-3 is linked to NF-κB activation, resulting in chemokine production. Granulocytes from healthy donors and NB4 cells were infected with M. catarrhalis in the presence of different inhibitors, blocking antibodies and siRNA. The supernatants were analysed by enzyme-linked immunosorbent assay for chemokines. NF-κB activation was determined using a luciferase reporter gene assay and chromatin-immunoprecipitation. We found evidence that the specific engagement of CEACAM3 by M. catarrhalis ubiquitous surface protein A1 (UspA1) results in the activation of pro-inflammatory events, such as degranulation of neutrophils, ROS production and chemokine secretion. The interaction of UspA1 with CEACAM3 induced the activation of the NF-κB pathway via Syk and the CARD9 pathway and was dependent on the phosphorylation of the CEACAM3 ITAM-like motif. These findings suggest that the CEACAM3 signalling in neutrophils is able to specifically modulate airway inflammation caused by infection with M. catarrhalis.
Subject(s)
CARD Signaling Adaptor Proteins/metabolism , Carcinoembryonic Antigen/metabolism , Granulocytes/physiology , Moraxella catarrhalis/physiology , Moraxellaceae Infections/microbiology , Syk Kinase/metabolism , Cell Degranulation , Chemokines/metabolism , Granulocytes/microbiology , HEK293 Cells , Host-Pathogen Interactions , Humans , Respiratory Burst , Signal TransductionABSTRACT
Introduction of a conjugated vaccine against encapsulated Haemophilus influenzae type b (Hib) has led to a dramatic reduction of invasive Hib disease. However, an increasing incidence of invasive disease by H. influenzae non-type b has recently been reported. Non-type b strains have been suggested to be opportunists in an invasive context, but information on clinical consequences and related medical conditions is scarce. In this retrospective study, all H. influenzae isolates (n = 410) from blood and cerebrospinal fluid in three metropolitan Swedish regions between 1997 and 2009 from a population of approximately 3 million individuals were identified. All available isolates were serotyped by PCR (n = 250). We observed a statistically significant increase in the incidence of invasive H. influenzae disease, ascribed to non-typeable H. influenzae (NTHi) and encapsulated strains type f (Hif) in mainly individuals >60 years of age. The medical reports from a subset of 136 cases of invasive Haemophilus disease revealed that 48% of invasive NTHi cases and 59% of invasive Hif cases, respectively, met the criteria of severe sepsis or septic shock according to the ACCP/SCCM classification of sepsis grading. One-fifth of invasive NTHi cases and more than one-third of invasive Hif cases were admitted to intensive care units. Only 37% of patients with invasive non-type b disease had evidence of immunocompromise, of which conditions related to impaired humoral immunity was the most common. The clinical burden of invasive non-type b H. influenzae disease, measured as days of hospitalization/100 000 individuals at risk and year, increased significantly throughout the study period.
Subject(s)
Bacteremia/epidemiology , Haemophilus Infections/epidemiology , Haemophilus influenzae/classification , Haemophilus influenzae/isolation & purification , Meningitis, Haemophilus/epidemiology , Adolescent , Adult , Age Factors , Aged , Aged, 80 and over , Bacteremia/microbiology , Blood/microbiology , Cerebrospinal Fluid/microbiology , Child , Child, Preschool , Female , Haemophilus Infections/microbiology , Hospitalization/statistics & numerical data , Humans , Incidence , Infant , Infant, Newborn , Male , Meningitis, Haemophilus/microbiology , Middle Aged , Polymerase Chain Reaction/methods , Retrospective Studies , Serotyping/methods , Sweden/epidemiology , Urban Population , Young AdultSubject(s)
Borrelia burgdorferi/immunology , Lyme Disease/diagnosis , Adolescent , Adult , Aged , Child , Child, Preschool , Enzyme-Linked Immunosorbent Assay , Female , Humans , Immunoblotting , Immunoglobulin G/blood , Immunoglobulin M/blood , Luminescent Measurements , Lyme Disease/immunology , Male , Middle Aged , Sensitivity and Specificity , Serologic Tests/methodsABSTRACT
The Moraxella immunoglobulin (Ig) D-binding protein (MID) induces a strong proliferative response in human peripheral blood IgD+ B cells from adults isolated by positive selection using anti-CD19-conjugated microbeads. Here, we show that tonsillar B cells from children isolated with positive selection are unable to respond to MID stimulation. The proliferative response was very low or absent at various concentrations of MID tested and at different time points analysed, whereas the MID response of tonsillar B cells from adults isolated with positive selection was considerably higher. Tonsillar B cells from children isolated with positive selection responded to formalin-fixed preparations of Moraxella catarrhalis and Staphylococcus aureus Cowan strain I. In comparison to cells isolated with positive selection, a much higher proliferative response was recorded in tonsillar B cells from children isolated with negative selection, indicating that occupation of the CD19 molecule (i.e. positive selection) inhibited the response. Indeed, the addition of anti-CD19 monoclonal antibodies (MoAb) to MID-activated tonsillar B cells from children isolated with negative selection strongly inhibited the proliferative response. In contrast, anti-CD21 MoAb at the same concentration did only show a minor inhibition on the MID-induced response. Pre-incubation of tonsillar B cells isolated from children with anti-CD19 or anti-CD21 MoAb did not affect the binding of biotin-conjugated MID as analysed by flow cytometry. These results suggest that MID-activated tonsillar B cells from children have a strong requirement for signalling through the CD19 molecule. Future experiments will further reveal the importance of CD19 and possibly other molecules for optimal activation of tonsillar B cells isolated from both children and adults.
Subject(s)
Antigens, CD19/immunology , B-Lymphocytes/immunology , Immunoglobulin D/immunology , Palatine Tonsil/immunology , Adult , Child , Child, Preschool , Enzyme-Linked Immunosorbent Assay , Flow Cytometry , Humans , Immunomagnetic Separation , Interleukin-6/immunology , Lymphocyte Activation/immunology , Moraxella catarrhalis/immunology , Palatine Tonsil/cytology , Staphylococcus aureus/immunologyABSTRACT
Fluorinated quinolones exert their bactericidal activity by inhibiting bacterial type II topoisomerases. At therapeutic concentrations, quinolones superinduce interleukin-2 (IL-2) and interferon-gamma production by mitogen-activated human peripheral blood T lymphocytes. At the molecular level, a stronger activation of the nuclear factor AP-1 ('activator protein-1') is observed in cells incubated with ciprofloxacin, resulting in enhanced cytokine gene transcription. Several cytokine and immediate early (e.g., c-fos and c-jun) mRNAs are upregulated by ciprofloxacin, possibly reflecting a mammalian stress response. In cultures with murine splenocytes, quinolones enhance IL-3 and granulocyte-macrophage colony stimulating factor (GM-CSF) synthesis. The stimulation of these hematopoietic growth factors prolongs survival of mice with depressed bone marrow and prevents experimental antiphospholipid syndrome (APS). In contrast, quinolones inhibit both human and mouse monocytic IL-1 and TNF-alpha synthesis, an effect that is beneficial in rat experimental type II collagen induced arthritis and LPS-induced septic chock in mice. The intriguing immunomodulatory activities of fluoroquinolones warrant future investigations with new tailored derivatives.
Subject(s)
Anti-Infective Agents/pharmacology , Immune System/drug effects , Animals , Antiphospholipid Syndrome/prevention & control , Cytokines/antagonists & inhibitors , Cytokines/biosynthesis , Fluoroquinolones , Humans , Lymphocyte Activation/drug effects , Phagocytosis/drug effects , SOS Response, Genetics , Thymidine/metabolismABSTRACT
Aside from their critical role in thrombosis, activated coagulation factors also have inflammatory properties and these may be important during delayed xenograft rejection (DXR). This study assessed whether porcine EC could be activated by factor Xa (FXa) and thrombin (FIIa) and whether expression of tissue factor pathway inhibitor (TFPI)-CD4 and hirudin-CD4 fusion proteins could prevent such activation. Incubation of porcine EC with human FXa and FIIa induced cell surface expression of E-selectin, VCAM and tissue factor (TF) in a time-dependent and concentration-dependent manner. In contrast, porcine EC transfected with a human TFPI-CD4 fusion protein were selectively resistant to these pro-inflammatory effects of FXa but not FIIa. Likewise, the transfectants expressing the hirudin-CD4 fusion protein were selectively resistant to the pro-inflammatory effects of FIIa but not those of FXa. When combined, the FXa and FIIa had an additive effect on the activation of control EC. In contrast, coexpression of both hirudin-CD4 and TFPI-CD4 fusion proteins completely inhibited the upregulation of VCAM with the FXa/FIIa mix. These results indicate that expression of novel anticoagulant fusion proteins on the surface of porcine EC can protect against EC activation induced by human coagulation factors FXa and FIIa. In vivo, we anticipate that expression of these fusion proteins on the endothelium of transplanted xenografts, besides preventing intravascular thrombosis, will also protect against EC activation induced by trace amounts of FIIa and FXa, thereby further protecting the grafts from DXR.
Subject(s)
Endothelium, Vascular/cytology , Factor Xa/pharmacology , Graft Rejection/prevention & control , Hirudins/physiology , Lipoproteins/physiology , Thrombin/pharmacology , Thrombosis/prevention & control , Animals , Blood Coagulation , CD4 Antigens/genetics , CD4 Antigens/physiology , Cell Adhesion , Cells, Cultured/drug effects , E-Selectin/biosynthesis , E-Selectin/genetics , Endothelium, Vascular/drug effects , Endothelium, Vascular/metabolism , Enzyme Activation , Gene Expression Regulation/drug effects , Hirudins/genetics , Humans , Lipoproteins/genetics , Postoperative Period , Prothrombin/pharmacology , Recombinant Fusion Proteins/physiology , Swine , Thromboplastin/biosynthesis , Thromboplastin/genetics , Thromboplastin/metabolism , Transfection , Vascular Cell Adhesion Molecule-1/biosynthesis , Vena Cava, Inferior/cytologyABSTRACT
Nontypeable Haemophilus influenzae (NTHi) is a common cause of respiratory tract infections. This study investigated the ability of NTHi to bind lipopolysaccharide-binding protein (LBP) derived from respiratory epithelial cells and the subsequent stimulation of transfected cells expressing membrane-bound CD14 and toll-like receptor 2 (TLR2) or TLR4. In the absence of LBP, NTHi at high concentrations (100 bacteria/epithelial cell) were required to induce signals through TLR2 and TLR4. Flow cytometry showed that NTHi in the stationary phase bound more LBP than did log-phase bacteria. Of interest, as few as 1 LBP-bearing bacterium/cell induced strong signaling through TLR4. In contrast, LBP bound to NTHi did not promote any increased signaling mediated by TLR2, compared with NTHi without LBP. These data suggest that, upon NTHi infection, low numbers of bacteria binding LBP may activate TLR4-bearing cells, such as alveolar macrophages, and consequently induce an inflammatory response.
Subject(s)
Acute-Phase Proteins/pharmacology , Carrier Proteins/pharmacology , Drosophila Proteins , Haemophilus influenzae/metabolism , Membrane Glycoproteins/drug effects , Receptors, Cell Surface/drug effects , Animals , CHO Cells , Cell Line , Cricetinae , Dose-Response Relationship, Drug , Haemophilus influenzae/growth & development , Humans , Lipopolysaccharide Receptors/genetics , Membrane Glycoproteins/genetics , Membrane Glycoproteins/metabolism , Protein Binding , Receptors, Cell Surface/genetics , Receptors, Cell Surface/metabolism , Signal Transduction/drug effects , Toll-Like Receptor 2 , Toll-Like Receptor 4 , Toll-Like Receptors , TransfectionABSTRACT
Protein D, having a glycerol-3-phosphodiester phosphodiesterase activity, is found at the surface of all Haemophilus influenzae strains and is a possible virulence factor. In the present study, the involvement of protein D in the entry of NTHi into human monocytic cells is reported. Primary monocytes and the monocytic cell lines U-937 and THP-1 were infected with NTHi strain 772 and the mutant 772 Delta hpd 1 (lacking the gene for protein D). NTHi 772 adhered to and entered monocytic cells up to four-fold more efficiently compared to 772 Delta hpd 1. When an Escherichia coli transformant expressing protein D was incubated with monocytic cells, the number of intracellular bacteria increased 1.6-fold compared to protein D-deficient controls. Any correlation between internalization and phosphorylcholine expression was not detected. In conclusion, our data suggest that surface-expressed protein D promotes the adherence of NTHi to human monocytes leading to a higher number of internalized bacteria.
Subject(s)
Bacterial Adhesion , Bacterial Proteins , Carrier Proteins/metabolism , Haemophilus influenzae/physiology , Immunoglobulin D , Lipoproteins/metabolism , Monocytes/metabolism , Monocytes/microbiology , Carrier Proteins/genetics , Escherichia coli/genetics , Escherichia coli/pathogenicity , Escherichia coli/physiology , Gene Deletion , Gene Expression Profiling , Gene Expression Regulation, Bacterial , Haemophilus influenzae/classification , Haemophilus influenzae/enzymology , Haemophilus influenzae/genetics , Humans , Lipoproteins/genetics , Phosphoric Diester Hydrolases/genetics , Phosphoric Diester Hydrolases/metabolism , Transformation, Bacterial , Tumor Cells, Cultured , U937 Cells , Virulence/geneticsABSTRACT
A novel surface protein of the bacterial species Moraxella catarrhalis that displays a high affinity for IgD (MID) was solubilized in Empigen and isolated by ion exchange chromatography and gel filtration. The apparent molecular mass of monomeric MID was estimated to approximately 200 kDa by SDS-PAGE. The mid gene was cloned and expressed in Escherichia coli. The complete mid nucleotide gene sequence was determined, and the deduced amino acid sequence consists of 2123 residues. The sequence of MID has no similarity to other Ig-binding proteins and differs from all previously described outer membrane proteins of M. catarrhalis. MID was found to exhibit unique Ig-binding properties. Thus, in ELISA, dot blots, and Western blots, MID bound two purified IgD myeloma proteins, four IgD myeloma sera, and finally one IgD standard serum. No binding of MID was detected to IgG, IgM, IgA, or IgE myeloma proteins. MID also bound to the surface-expressed B cell receptor IgD, but not to other membrane molecules on human PBLs. This novel Ig-binding reagent promises to be of theoretical and practical interest in immunological research.
Subject(s)
Adhesins, Bacterial , Bacterial Proteins/chemistry , Bacterial Proteins/isolation & purification , Carrier Proteins/chemistry , Carrier Proteins/isolation & purification , Immunoglobulin D/metabolism , Moraxella catarrhalis/metabolism , Amino Acid Sequence , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Base Sequence , Carrier Proteins/genetics , Carrier Proteins/metabolism , Cloning, Molecular , Escherichia coli/genetics , Escherichia coli/immunology , Gene Expression Regulation/immunology , Genetic Vectors/immunology , Humans , Molecular Sequence Data , Protein Binding/immunology , Sequence Analysis, ProteinABSTRACT
Previous reports showed that nontypeable Haemophilus influenzae (NTHi) reside in macrophage-like cells in human adenoid tissue. This study investigated the ability of nonopsonized NTHi and encapsulated H. influenzae type b (Hib) to enter human monocytic and epithelial cells. The number of intracellular bacteria was determined by a viability assay and flow cytometry. To characterize the mechanisms responsible for the internalization of NTHi, different inhibitors of surface molecules, receptor turnover, and the cytoskeleton were used. Hib were found in monocytic cells at very low numbers (<100 bacteria/2x105 cells). In contrast, a great variation in intracellular numbers was detected between the different NTHi isolates (range, 0.0007%-0.28% of the inoculum for monocytes and 0.053%-3.5% for epithelial cells). NTHi entered human monocytic and epithelial cells via a receptor-mediated endocytosis involving mainly a beta-glucan receptor that could be blocked by laminarin.
Subject(s)
Epithelial Cells/metabolism , Haemophilus influenzae/metabolism , Monocytes/metabolism , Receptors, Cell Surface , Receptors, G-Protein-Coupled , Receptors, Immunologic/metabolism , Carcinoma/metabolism , Flow Cytometry , Fluorescence , Humans , Leukemia, Monocytic, Acute/metabolism , Lung Neoplasms/metabolism , Mannose/antagonists & inhibitors , Microscopy, Electron , Platelet Membrane Glycoproteins/antagonists & inhibitors , Receptors, Immunologic/antagonists & inhibitors , Tumor Cells, CulturedSubject(s)
Endothelium, Vascular/physiology , Thromboplastin/metabolism , Thrombosis/prevention & control , Animals , Cells, Cultured , Hirudins/genetics , Humans , Leeches , P-Selectin/genetics , P-Selectin/physiology , Recombinant Fusion Proteins/biosynthesis , Swine , Thromboplastin/genetics , Transplantation, Heterologous/physiology , Transplantation, Homologous/physiology , Vena Cava, InferiorSubject(s)
Cytotoxicity Tests, Immunologic , Enterotoxins/metabolism , Receptors, Antigen, T-Cell/metabolism , Staphylococcus aureus/immunology , Superantigens/metabolism , T-Lymphocytes, Cytotoxic/immunology , Animals , Cells, Cultured , Chromium Radioisotopes/metabolism , Cytotoxicity, Immunologic , Enterotoxins/immunology , Humans , Lymphocyte Activation , Mice , Receptors, Antigen, T-Cell/immunology , Superantigens/immunologyABSTRACT
A cluster of a Neisseria meningitidis serogroup C strain causing invasive disease was investigated. Five out of seven cases were associated with a particular discotheque. The strains were indistinguishable, as revealed by pulsed-field gel electrophoresis and sequencing of variable regions of the porA gene, but caused strikingly different clinical presentations during 5 months.
Subject(s)
Dancing , Disease Outbreaks , Electrophoresis, Gel, Pulsed-Field , Meningococcal Infections/epidemiology , Neisseria meningitidis/pathogenicity , Porins/genetics , Adolescent , Adult , Child , Child, Preschool , Female , Humans , Infant , Male , Meningococcal Infections/microbiology , Middle Aged , Neisseria meningitidis/classification , Neisseria meningitidis/genetics , Sweden/epidemiologyABSTRACT
BACKGROUND: Thrombotic vascular occlusion resulting in infarction occurs during hyperacute rejection of allografts transplanted into sensitized patients and remains a major problem in experimental xenotransplantation. A similar process is also found in disorders of diverse etiology including atherosclerosis, vasculitis, and disseminated intravascular coagulation. METHODS: We have previously constructed two membrane-tethered anticoagulant fusion proteins based on human tissue factor pathway inhibitor and the leech anticoagulant hirudin and demonstrated their functional efficacy in vitro. These constructs have now been modified by the addition of a P-selectin sequence to the cytoplasmic tail to localize them in Weibel-Palade bodies. They have been transfected into Weibel-Palade body-positive endothelial cells isolated from the inferior vena cava of normal pigs. RESULTS: In resting endothelial cells, fusion protein expression colocalized with P-selectin and was confined to Weibel-Palade bodies. These cells had a procoagulant phenotype in recalcified human plasma. However, after activation with phorbol ester the anticoagulant proteins were rapidly relocated to the cell surface where they specifically inhibited the clotting of human plasma. CONCLUSIONS: Novel anticoagulant molecules may prove useful therapeutic agents for gene therapy in thrombotic disease and postangioplasty or for transgenic expression in animals whose organs may be used for clinical xenotransplantation. Expression in vascular endothelial cells may be regulated by inclusion of P-selectin cytoplasmic sequence, to restrict cell surface expression to activated endothelium.